CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 29 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,220,000 | -21.2% | 400,000 | 0.0% | 0.20% | -65.3% |
| Q4 2021 | $1,548,000 | -26.6% | 400,000 | 0.0% | 0.56% | +5.6% |
| Q3 2021 | $2,108,000 | -6.3% | 400,000 | +5.3% | 0.53% | -33.9% |
| Q2 2021 | $2,250,000 | -16.7% | 380,000 | 0.0% | 0.80% | -12.3% |
| Q1 2021 | $2,702,000 | +194.3% | 380,000 | +223.3% | 0.92% | +88.5% |
| Q4 2020 | $918,000 | – | 117,545 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 462,659 | $1,411,000 | 0.58% |
| Sio Capital Management, LLC | 422,598 | $1,289,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,550,000 | 0.22% |
| Affinity Asset Advisors, LLC | 400,000 | $1,220,000 | 0.20% |
| Atom Investors LP | 31,385 | $96,000 | 0.04% |
| Ikarian Capital, LLC | 104,741 | $319,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 514,780 | $1,570,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 77,568 | $237,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $702,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,934 | $179,000 | 0.00% |